Summaries of preclinical peptide research: mechanisms, studied pathways and what the literature actually shows.
They are sold as a pair. One controlled study compared them directly and tested the combination. The combination did not win.
4 min read
Software, hardware and fuel. Three compounds, three failure points, and three very different amounts of evidence behind them.
One targets two receptors, the other three. The published trials show what that difference has and has not been shown to buy.
How two of the most-studied repair peptides are thought to support tissue recovery in preclinical models.
1 min read
A look at why NAD+ and Epitalon feature so heavily in longevity research protocols.
